This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even experienced — the short-term side effects of Ozempic — such as nausea, vomiting, constipation, and ... Novo Nordisk said Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year.

Understanding the Context

The company said the FDA has approved ... Learn why rapid weight loss may trigger hair loss with Ozempic and discover ways to minimize shedding and regrow your hair. Seeking Alpha: Novo Nordisk to launch the Ozempic pill in Q2 2026 Novo Nordisk (NVO) on Wednesday announced plans to launch some doses of its oral GLP-1 receptor agonist semaglutide under the brand name Ozempic pill in Q2 2026, following a successful commercial ... MSN: Novo Nordisk to launch Ozempic pills following flat growth in diabetes segment in 2025 Novo Nordisk to launch Ozempic pills following flat growth in diabetes segment in 2025 AOL: Novo to launch Ozempic pill for diabetes in second quarter of this year